Experienced in Ampullary Cancer

Jianbin S. Xiang

12 Middle Urumqi Road, 
Shanghai, CN 
Experienced in Ampullary Cancer
12 Middle Urumqi Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Jianbin Xiang practices in Shanghai, China. Xiang is rated as an Experienced expert by MediFind in the treatment of Ampullary Cancer. Their top areas of expertise are Colorectal Cancer, Ampullary Cancer, Gangrene, and Ileostomy.

Their clinical research consists of co-authoring 53 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Ampullary Cancer.

Locations

12 Middle Urumqi Road, Shanghai, 200040, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Exploratory Study on the Efficacy and the Safety of mFOLFOX6 Chemotherapy With Apatinib as Postoperative Treatment in Stage IIIB or IIIC Colorectal Cancer
Exploratory Study on the Efficacy and the Safety of mFOLFOX6 Chemotherapy With Apatinib as Postoperative Treatment in Stage IIIB or IIIC Colorectal Cancer
Enrollment Status: Completed
Publish Date: February 14, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Single Center, Open, Randomized Clinical Trials, Effectiveness and Safety Study on Different Timing of Preventive Ileostomy Closure After Total Mesorectal Excision for Middle and Low Rectal Cancer
A Single Center, Open, Randomized Clinical Trials, Effectiveness and Safety Study on Different Timing of Preventive Ileostomy Closure After Total Mesorectal Excision for Middle and Low Rectal Cancer
Enrollment Status: Completed
Publish Date: September 21, 2021
Intervention Type: Procedure
Study Phase: Not Applicable
A Single Center, Open, Randomized Clinical Trial：Study on the Efficacy and Safety of Enhanced Recovery After Surgery （ERAS）in Gastrointestinal Cancer
A Single Center, Open, Randomized Clinical Trial：Study on the Efficacy and Safety of Enhanced Recovery After Surgery （ERAS）in Gastrointestinal Cancer
Enrollment Status: Completed
Publish Date: September 21, 2021
Intervention Type: Procedure
Study Phase: Not Applicable
View 2 Less Clinical Trials

53 Total Publications

NUDT21-mediated Alternative Polyadenylation of CDK19 Reprograms Cholesterol Biosynthesis to Drive Colorectal Cancer Progression.
NUDT21-mediated Alternative Polyadenylation of CDK19 Reprograms Cholesterol Biosynthesis to Drive Colorectal Cancer Progression.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Xiang's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile